Remove DCF Remove Debt Remove Pharmaceutical
article thumbnail

The Full Guide to Healthcare Private Equity, from Careers to Contradictions

Mergers and Inquisitions

PE firms view these companies as especially appealing since low multiples mean they can use higher debt percentages to fund the acquisitions. This deal works because SYNLAB can afford to take on a huge amount of Debt and can likely repay it quickly – since its EBITDA was depressed at the time of this acquisition.